Interferon resistance of emerging SARS-CoV-2 variants

被引:63
|
作者
Guo, Kejun [1 ]
Barrett, Bradley S. [1 ]
Morrison, James H. [1 ]
Mickens, Kaylee L. [1 ,2 ]
Vladar, Eszter K. [3 ]
Hasenkrug, Kim J. [4 ]
Poeschla, Eric M. [1 ,2 ]
Santiago, Mario L. [1 ,2 ]
机构
[1] Univ Colorado, Div Infect Dis, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA
[2] Univ Colorado, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO 80045 USA
[3] Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Anschutz Med Campus, Aurora, CO 80045 USA
[4] NIAID, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA
基金
美国国家卫生研究院;
关键词
SARS-CoV-2; COVID-19; interferons; innate immunity; variants of concern; I INTERFERON; ALPHA; IFN; LANDSCAPE; EMERGENCE; INFECTION; RESPONSES; SUBTYPES; LINEAGE; BETA;
D O I
10.1073/pnas.2203760119
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The emergence of SARS-CoV-2 variants with enhanced transmissibility, pathogenesis, and resistance to vaccines presents urgent challenges for curbing the COVID-19 pandemic. While Spike mutations that enhance virus infectivity or neutralizing antibody evasion may drive the emergence of these novel variants, studies documenting a critical role for interferon responses in the early control of SARS-CoV-2 infection, combined with the presence of viral genes that limit these responses, suggest that interferons may also influence SARS-CoV-2 evolution. Here, we compared the potency of 17 different human interferons against multiple viral lineages sampled during the course of the global outbreak, including ancestral and five major variants of concern that include the B.1.1.7 (alpha), B.1.351 (beta), P.1 (gamma), B.1.617.2 (delta), and B.1.1.529 (omicron) lineages. Our data reveal that relative to ancestral isolates, SARS-CoV-2 variants of concern exhibited increased interferon resistance, suggesting that evasion of innate immunity may be a significant, ongoing driving force for SARS-CoV-2 evolution. These findings have implications for the increased transmissibility and/or lethality of emerging variants and highlight the interferon subtypes that may be most successful in the treatment of early infections.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
    Skelly, Donal T.
    Harding, Adam C.
    Gilbert-Jaramillo, Javier
    Knight, Michael L.
    Longet, Stephanie
    Brown, Anthony
    Adele, Sandra
    Adland, Emily
    Brown, Helen
    Chinnakannan, Senthil
    Chinnakannan, Senthil
    Donnison, Timothy
    Ali, Mohammad
    Rongkard, Patpong
    Pace, Matthew
    Zacharopoulou, Peny
    Robinson, Nicola
    Csala, Anna
    De Lara, Cathy
    Hutchings, Claire L.
    Mehta, Hema
    Lee, Lian Ni
    Edmans, Matthew
    Hackstein, Carl-Philipp
    Phalora, Prabhjeet
    Li, Wenqin
    Phillips, Eloise
    Malone, Tom
    Ogbe, Ane
    Jay, Cecilia
    Tipoe, Timothy
    Tipton, Tom
    Stafford, Lizzie
    Mentzer, Alexander J.
    Johnson, Sile A.
    Amini, Ali
    Marjot, Thomas
    Marjot, Thomas
    Dimitriadis, Stavros
    Simmons, Beatrice
    Deeks, Alexandra
    Kerneis, Sven
    Abuelgasim, Hibatullah
    Wilson, Robert
    Thomas, Sarah R.
    Watson, Adam
    Alhussni, Ahmed
    Cutteridge, Joseph
    Weeks, Esme
    Denly, Lucy
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [42] Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
    Donal T. Skelly
    Adam C. Harding
    Javier Gilbert-Jaramillo
    Michael L. Knight
    Stephanie Longet
    Anthony Brown
    Sandra Adele
    Emily Adland
    Helen Brown
    Tom Tipton
    Lizzie Stafford
    Alexander J. Mentzer
    Síle A. Johnson
    Ali Amini
    Tiong Kit Tan
    Lisa Schimanski
    Kuan-Ying A. Huang
    Pramila Rijal
    John Frater
    Philip Goulder
    Christopher P. Conlon
    Katie Jeffery
    Christina Dold
    Andrew J. Pollard
    Alex Sigal
    Tulio de Oliveira
    Alain R. Townsend
    Paul Klenerman
    Susanna J. Dunachie
    Eleanor Barnes
    Miles W. Carroll
    William S. James
    Nature Communications, 12
  • [43] Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
    Gomez, Carmen Elena
    Perdiguero, Beatriz
    Esteban, Mariano
    VACCINES, 2021, 9 (03) : 1 - 13
  • [44] Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan
    Chhoung, Chanroth
    Ko, Ko
    Ouoba, Serge
    Phyo, Zayar
    Akuffo, Golda Ataa
    Sugiyama, Aya
    Akita, Tomoyuki
    Sasaki, Hiroshi
    Yamamoto, Tadashi
    Takahashi, Kazuaki
    Tanaka, Junko
    BMC GENOMICS, 2024, 25 (01):
  • [45] SARS-CoV-2 and interferon blockade
    Betty Diamond
    Bruce T. Volpe
    Sonya VanPatten
    Yousef Al Abed
    Molecular Medicine, 2020, 26
  • [46] SARS-CoV-2 and interferon blockade
    Diamond, Betty
    Volpe, Bruce T.
    VanPatten, Sonya
    Al Abed, Yousef
    MOLECULAR MEDICINE, 2020, 26 (01)
  • [47] SARS-CoV-2 Variants and Vaccines
    Krause, Philip R.
    Fleming, Thomas R.
    Longini, Ira M.
    Peto, Richard
    Briand, Sylvie
    Heymann, David L.
    Beral, Valerie
    Snape, Matthew D.
    Rees, Helen
    Ropero, Alba-Maria
    Balicer, Ran D.
    Cramer, Jakob P.
    Munoz-Fontela, Cesar
    Gruber, Marion
    Gaspar, Rogerio
    Singh, Jerome A.
    Subbarao, Kanta
    Van Kerkhove, Maria D.
    Swaminathan, Soumya
    Ryan, Michael J.
    Henao-Restrepo, Ana-Maria
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (02): : 179 - 186
  • [48] The SARS-CoV-2 Variants and their Impacts
    Shukri, Amir Muhaimin Akmal
    Wang, Seok Mui
    Chia, Suet Lin
    Nawi, Siti Farah Alwani Mohd
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2022, 16 (03): : 1409 - 1424
  • [49] New variants of SARS-CoV-2
    Canton, Rafael
    De Lucas Ramos, Pilar
    Garcia-Botella, Alejandra
    Garcia-Lledo, Alberto
    Gomez-Pavon, Javier
    Gonzalez del Castillo, Juan
    Hernandez-Sampelayo, Teresa
    Cruz Martin-Delgado, Mari
    Martin Sanchez, Francisco Javier
    Martinez-Selles, Manuel
    Molero Garcia, Jose Maria
    Moreno Guillen, Santiago
    Rodriguez-Artalejo, Fernando
    Ruiz-Galiana, Julian
    Bouza, Emilio
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 (05) : 419 - 428
  • [50] The names of the SARS-CoV-2 variants
    不详
    PANACEA-BOLETIN DE MEDICINA Y TRADUCCION, 2021, 22 (54): : 92 - 92